VIEWPOINTSPharmaShots Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted TherapiesBySenior EditorJune 11, 20210Comments
VIEWPOINTSPharmaShots Interview: Apellis’ Federico Grossi Shares Insights on the Data in GA Presented at ARVO 2021BySenior EditorJune 9, 20210Comments
VIEWPOINTSPharmaShots Interview: GSK’s Mike Crichton Shares Insights on the Approval of Benlysta in EuropeBySenior EditorJune 8, 20210Comments
VIEWPOINTSPharmaShots Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2BySenior EditorJune 7, 20210Comments
VIEWPOINTSPharmaShots Interview: bluebird bio’s Rich Colvin Shares Insights on the Skysona to Treat Early Cerebral AdrenoleukodystrophyBySenior EditorJune 4, 20210Comments
VIEWPOINTSPharmaShots Interview: Daiichi Sankyo’s Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast CancerBySenior EditorJune 2, 20210Comments
VIEWPOINTSPharmaShots Interview: Aurinia’s Neil Solomons Shares Insights on the LupkynisBySenior EditorJune 1, 20210Comments
